Role of prophylactic colectomy in Lynch syndrome

Clinical Colorectal Cancer

Volumn 3, Issue 2, 2003, Pages 99-101

  Lynch, Henry T ^a   Lynch, Jane F ^a   Fitzgibbons Jr , Robert ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ABDOMINAL HYSTERECTOMY; ADENOMATOUS POLYP; CANCER CONTROL; CANCER PREVENTION; CANCER RISK; COLON CARCINOGENESIS; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; FAMILIAL CANCER; GENE MUTATION; GENETIC DISORDER; GERM LINE; HUMAN; ILEOSTOMY; INTESTINE ENDOSCOPY; LAPAROSCOPY; MEDICAL DECISION MAKING; NOTE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PREOPERATIVE CARE; PROCTOCOLECTOMY; RECTUM CANCER; RISK ASSESSMENT; SALPINGOOOPHORECTOMY; SURGICAL TECHNIQUE; TREATMENT PLANNING;

EID: 0042884030     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1533-0028(11)70074-3     Document Type: Note

References (17)

1. Scaife CL, Rodriguez-Bigas MA. Lynch syndrome-implication for the surgeon. Clinical Colorectal Cancer 2003; 3:92-98.
2. Rodriguez-Bigas MA, Vasen HF, Pekka-Mecklin J, et al. Rectal cancer risk in hereditary non-polyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg 1997; 225:202-207.
3. van Laarhoven CJ, Andriesse GI, Schipper ME, et al. Ileoneorectal anastomosis: early clinical results of a restorative procedure for ulcerative colitis and familial adenomatous polyposis without formation of an ileoanal pouch. Ann Surg 1999; 230:750-757.
4. Lynch HT. Is there a role for prophylactic subtotal colectomy among hereditary non-polyposis colorectal cancer germline mutation carriers? Dis Colon Rectum 1996; 39:109-110.
5. Church JM. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. Ann Med 1996; 28:479-482.
6. DeCosse JJ. Surgical prophylaxis of familial colon cancer: prevention of death from familial colorectal cancer. J Natl Cancer Inst Monogr 1995:31-32.
7. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999; 36:801-818.
8. Jass JR, Stewart SM. Evolution of hereditary non-polyposis colorectal cancer. Gut 1992; 33:783-786.
9. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36:2251-2270.
10. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348:919-932.
11. Jass JR, Smyrk TC, Stewart SM, et al. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 1994; 14:1631-1634.
12. Rodriguez-Bigas MA, Petrelli NJ. Management of hereditary colon cancer syndromes. In: Saltz LB, ed. Colorectal Cancer: Multimodality Management. Totoa, NJ: Humana Press, 2002:99-114.
13. Green SE, Bradburn DM, Varma JS, et al. Hereditary non-polyposis colorectal cancer. Int J Colorectal Dis 1998; 13:3-12.
14. Syngal S, Weeks JC, Schrag D, et al. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary non-polyposis colorectal cancer mutations. Ann Intern Med 1998; 129:787-796.
15. Rodriguez-Bigas MA. Prophylactic colectomy for gene carriers in hereditary nonpolyposis colorectal cancer. Has the time come? Cancer 1996; 78:199-201.
16. Anwar S, Hall C, White J, et al. Hereditary non-polyposis colorectal cancer: an updated review. Eur J Surg Oncol 2000; 26:635-645.
17. Moslein G, Pistorius S, Saeger HD, et al. Preventive surgery for colon cancer in familial adenomatous polyposis and hereditary non-polyposis colorectal cancer syndrome. Langenbecks Arch Surg 2003; 388:9-16.